Page 15 - HFA Dateline 2019-2020 Special Issue
P. 15
Current Products
on the Market
The list products currently on the market contains
information in following categories:
Manufacturer:
Company that produces and sells the therapy.
Product:
Name used to market and sell the therapy.
Type:
Indicated method used to create product (plasma-derived, made from human blood, or recombinant
factor concentrates, made from other sources).
Half Life:
Amount of time a product stays intact in the bloodstream until its efficacy is halved.
FDA Approved:
Year the product was approved for treatment by the FDA.
Indications:
Bleeding disorder type/factor deficiency the therapy is intended to treat.
We’ve made every effort to ensure the accuracy of the information in this list by using information directly
from manufacturers and publicly-available information from websites, such as the FDA. HFA does not
encourage community members to use one product over another, and strongly urges you discuss your
treatment options with qualified medical professionals.
Content in this issue is current as of March 2020. Given the fast-paced environment that manufacturers
and governmental agencies work within, some information could have changed since going to print.
Please refer to manufacturers’ or the FDA’s websites for the most up-to-date information. S
SPECIAL ISSUE 2019-2020 15
